These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 9147928)
1. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute. Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928 [TBL] [Abstract][Full Text] [Related]
2. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity. Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499 [TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy? Bacci G; Picci P; Gherlinzoni F; Van Horn JR; Orlandi M; Normand AR; Manfrini M; Pignatti G; Campanacci M Chemioterapia; 1986 Apr; 5(2):140-3. PubMed ID: 3458546 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results. Bacci G; Picci P; Ferrari S; Sangiorgi L; Mercuri M; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Comandone A Chir Organi Mov; 1995; 80(1):1-10. PubMed ID: 7641534 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the limbs. Preliminary results in 100 patients treated preoperatively with high doses of methotrexate i.v. followed by cisplatin (i.a.) and adriamycin. Bacci G; Picci P; Ruggieri P; Avella M; Mercuri M; Capanna R; Biagini R; Tienghi C; Mancini A; Brach del Prever A Chir Organi Mov; 1991; 76(1):1-16. PubMed ID: 1893781 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases. Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary results. Bacci G; Avella M; Brach Del Prevert A; Capanna R; Fiorentini G; Malaguti C; Picci P; Rosito P; Campanacci M Chemioterapia; 1988 Apr; 7(2):138-42. PubMed ID: 3165058 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997 [TBL] [Abstract][Full Text] [Related]
10. Influence of adriamycin dose in the outcome of patients with osteosarcoma treated with multidrug neoadjuvant chemotherapy: results of two sequential studies. Bacci G; Picci P; Ferrari S; Casadei R; Brach Del Prever A; Tienghi A; Mancini A J Chemother; 1993 Aug; 5(4):237-46. PubMed ID: 8229152 [TBL] [Abstract][Full Text] [Related]
11. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan. Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinum. Bacci G; Avella M; Capanna R; Boriani S; Dallari D; Galletti S; Giunti A; Madon E; Mancini A; Mercuri M Ital J Orthop Traumatol; 1988 Mar; 14(1):23-39. PubMed ID: 3235324 [TBL] [Abstract][Full Text] [Related]
13. Intra-arterial versus intravenous cisplatinum (in addition to systemic Adriamycin and high dose methotrexate) in the neoadjuvant treatment of osteosarcoma of the extremities. results of a randomized study. Bacci G; Ruggieri P; Picci P; Mercuri M; Ferraro A; Tella G; Ferrari S; Bertoni F; Comandone A J Chemother; 1996 Feb; 8(1):70-81. PubMed ID: 8835114 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol. Bacci G; Ferrari S; Longhi A; Forni C; Bertoni F; Fabbri N; Zavatta M; Versari M J Chemother; 2001 Feb; 13(1):93-9. PubMed ID: 11233808 [TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients]. Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy for malignant fibrous histiocytoma of bone and for osteosarcoma of the limbs: a comparison between the results obtained for 21 and 144 patients, respectively, treated during the same period with the same chemotherapy protocol. Bacci G; Mercuri M; Ruggieri P; Ferraro A; Bertoni F; Tella G; Ferrari S; Iantorno D Chir Organi Mov; 1996; 81(2):139-53. PubMed ID: 8968117 [TBL] [Abstract][Full Text] [Related]
17. No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma. Bacci G; Loro L; Longhi A; Bertoni F; Bacchini P; Versari M; Picci P; Serra M Anticancer Drugs; 2006 Apr; 17(4):411-5. PubMed ID: 16549998 [TBL] [Abstract][Full Text] [Related]
18. Intensified chemotherapy with ifosfamide (IFO) and influence of intraarterial (i.a.) versus intravenous (i.v.) infusion of cisplatinum (DDP). Preliminary results. Winkler K; Bielack S; Delling G; Salzer-Kuntschik M; Purfürst C; Heise U; Jürgens H; Kotz R; Gadner H; Ritter J Chir Organi Mov; 1990; 75(1 Suppl):54-6. PubMed ID: 2249558 [No Abstract] [Full Text] [Related]
19. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study. Thiele OC; Freier K; Bacon C; Egerer G; Hofele CM Br J Oral Maxillofac Surg; 2008 Oct; 46(7):533-6. PubMed ID: 18436357 [TBL] [Abstract][Full Text] [Related]
20. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]